Ilex Medical Ltd (ILX.TA)

ILA 7923.0

(-1.55%)

Market Cap (In ILA)

886.43 Million

Revenue (In ILA)

930.89 Million

Net Income (In ILA)

50.88 Million

Avg. Volume

4070.00

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
5600.0-8499.0
PE
-
EPS
-
Beta Value
-0.094
ISIN
IL0010807530
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Tamar Galili
Employee Count
-
Website
https://www.ilexmedical.com
Ipo Date
2002-08-12
Details
Ilex Medical Ltd engages in marketing, selling, and supporting equipment, disposables, and reagents for laboratories and healthcare establishments in Israel and South Africa. The company offers in vitro diagnostic equipment and reagent systems to hospitals, clinics, and other medical institutions; molecular biology products for cancer screening, retro virus viral load, TB, STDs, and other infectious diseases; and equipment, disposables, and reagents for in vitro fertilization, as well as food and pharma industries. It also distributes and supports nucleic acid testing blood screening solutions to large-scale blood banks; provides pre/post analytics and robotics; and develops, markets, implements, and supports laboratory information systems. In addition, the company offers specialized product range that includes molecular diagnostics, critical care, and immunology products. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel.